Bahamas - Import of Heparin for Therapeutic Use
Since 2010, Bahamas Import of Heparin for Therapeutic Use was down by 20.3% year on year. At $41,796 in 2015, the country was number 104 among other countries in Import of Heparin for Therapeutic Use. Bahamas is overtaken by Latvia, which was number 103 with $42,728.1 and is followed by French Polynesia at $39,023. France lead the ranking with $960,128,653.6 in 2019, that is -6.6% versus 2018. United States, Singapore and Germany respectively ranked number 2, 3 and 4 in this ranking. Belize witnessed the best average annual growth at +183.7% per year, while Mauritania was the worst growing country at -81.7% per year.
Loading...
Date | US Dollars |
---|---|
2015 | 41,796.00 |
2014 | 6,130.00 |
2013 | 2,447.00 |
2012 | 1,798.00 |
2011 | 11,901.00 |
Download all data from 1997 to 2015
How does Bahamas rank in Import of Heparin for Therapeutic Use?
# | 152 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
France
|
960,128,653.60 | 2019 | -6.6 % | -5.3 % | View data | |
2 |
#2
United States
|
422,842,642.50 | 2019 | +0.9 % | +2.3 % | View data | |
103 |
#103
Latvia
|
42,728.10 | 2019 | +2.5 % | +2.1 % | View data | |
104 |
#104
Bahamas
|
41,796.00 | 2015 | +581.8 % | -20.3 % | View data | |
105 |
#105
French Polynesia
|
39,023.00 | 2019 | -0.6 % | -4.0 % | View data |